Neuronetics appoints Megan Rosengarten to Board of Directors, effective August 2, 2021

Neuronetics, Inc.

Megan Rosengarten appointed as director and member of the Compensation Committee.
Rosengarten currently serves as President of Surgical Robotics at Medtronic.
Board expands to eight members; Rosengarten's term expires at 2022 annual meeting.
She qualifies as independent under SEC and Nasdaq standards.
No arrangements or family relationships with officers; standard director compensation applies.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Megan Rosengarten

Director

STIM · Neuronetics, Inc.

Effective: 2021-08-02
Filed: August 6, 2021, 7:59 PM ET

appointed Megan Rosengarten as a director and member of the Board’s Compensation Committee.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Megan Rosengarten was appointed as Director at Neuronetics, Inc..

Action: appointed
Role: Director

Exact text from the filing

appointed Megan Rosengarten as a director and member of the Board’s Compensation Committee.

View on SEC.gov

Neuronetics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-21-238135

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.